指南与共识流行病学与生物统计医学教育与科研方法

儿童和青少年焦虑筛查:美国预防服务工作组推荐声明

Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement.
指南 / 共识 · JAMA · 2022-01-01

美国预防服务工作组(USPSTF)基于系统综述评估儿童和青少年焦虑筛查的获益与危害,结论为对8至18岁儿童和青少年焦虑筛查有中等净获益(B推荐),对7岁及以下儿童证据不足(I声明)。

要点

  • USPSTF推荐对8至18岁儿童和青少年进行焦虑筛查(B推荐)。
  • USPSTF认为7岁及以下儿童焦虑筛查的获益与危害证据不足(I声明)。
  • 2018-2019年全国儿童健康调查显示,3至17岁儿童和青少年中7.8%患有当前焦虑障碍。

核心结论

  • USPSTF以中等确定性结论认为,对8至18岁儿童和青少年进行焦虑筛查具有中等净获益,推荐筛查(B推荐)。
  • USPSTF结论认为,7岁及以下儿童焦虑筛查的获益与危害证据不足(I声明)。

研究设计与样本

  • USPSTF委托系统综述评估儿童和青少年焦虑障碍筛查的获益与危害,形成此新推荐声明。

主要发现

  • 2018-2019年全国儿童健康调查发现,3至17岁儿童和青少年中7.8%患有当前焦虑障碍。
  • 儿童和青少年焦虑障碍与未来发生焦虑障碍或抑郁的可能性增加相关。

关键数值与推荐

  • 推荐对8至18岁儿童和青少年进行焦虑筛查(B推荐)。
  • 7岁及以下儿童焦虑筛查的获益与危害证据不足(I声明)。

临床怎么用

  • 原文未据此给出具体临床操作推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Anxiety disorder, a common mental health condition in the US, comprises a group of related conditions characterized by excessive fear or worry that present as emotional and physical symptoms. The 2018-2019 National Survey of Children's Health found that 7.8% of children and adolescents aged 3 to 17 years had a current anxiety disorder. Anxiety disorders in childhood and adolescence are associated with an increased likelihood of a future anxiety disorder or depression. OBJECTIVE: The US Preventive Services Task Force (USPSTF) commissioned a systematic review to evaluate the benefits and harms of screening for anxiety disorders in children and adolescents. This is a new recommendation. POPULATION: Children and adolescents 18 years or younger who do not have a diagnosed anxiety disorder or are not showing recognized signs or symptoms of anxiety. EVIDENCE ASSESSMENT: The USPSTF concludes with moderate certainty that screening for anxiety in children and adolescents aged 8 to 18 years has a moderate net benefit. The USPSTF concludes that the evidence is insufficient on screening for anxiety in children 7 years or younger. RECOMMENDATION: The USPSTF recommends screening for anxiety in children and adolescents aged 8 to 18 years. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for anxiety in children 7 years or younger. (I statement).

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Mangione CM, Barry MJ, Nicholson WK, et al. Screening for Anxiety in Children and Adolescents: US Preventive Services Task Force Recommendation Statement. JAMA. 2022. PMID: 36219403. doi:10.1001/jama.2022.16936

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。